Gregory Jankilevitsch serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Gregory Jankilevitsch has executed 1 insider transactions totaling $17.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 23, 2014 involved selling 500,000 shares valued at $17.8M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 23, 2014 | KPTI | $17.8M | Sale | 500,000 | $35.54 | Discretionary |
Gregory Jankilevitsch currently holds 2,693,473 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Jankilevitsch has been a net seller of KPTI stock. They have purchased $0 and sold $17.8M worth of shares.
Gregory Jankilevitsch's most recent insider trade was on Jul 23, 2014, when they sold 500,000 shares at $35.54 per share.
Get notified when new Form 4 filings are submitted